» Articles » PMID: 37131013

Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study

Overview
Journal Drug Saf
Specialties Pharmacology
Toxicology
Date 2023 May 2
PMID 37131013
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: It is unknown whether the cardiovascular risks associated with non-steroidal anti-inflammatory drug (NSAID) use differ according to lifestyle and socioeconomic position.

Objective: We examined the association between NSAID use and major adverse cardiovascular events (MACE) within subgroups defined by lifestyle and socioeconomic position.

Methods: We conducted a case-crossover study of all adult first-time respondents to the Danish National Health Surveys of 2010, 2013, or 2017, without previous cardiovascular disease, who experienced a MACE from survey completion through 2020. We used a Mantel-Haenszel method to obtain odds ratios (ORs) of the association between NSAID use (ibuprofen, naproxen, or diclofenac) and MACE (myocardial infarction, ischemic stroke, heart failure, or all-cause death). We identified NSAID use and MACE via nationwide Danish health registries. We stratified the analyses by body mass index, smoking status, alcohol consumption, physical activity level, marital status, education, income, and employment.

Results: Compared with non-use, the OR of MACE was 1.34 (95% confidence interval: 1.23-1.46) for ibuprofen, 1.48 (1.04-2.43) for naproxen, and 2.18 (1.72-2.78) for diclofenac. When comparing NSAID use with non-use or the individual NSAIDs with each other, we observed no notable heterogeneity in the ORs within subgroups of lifestyle and socioeconomic position for any NSAID. Compared with ibuprofen, diclofenac was associated with increased risk of MACE in several subgroups with high cardiovascular risk, e.g., individuals with overweight (OR 1.52, 1.01-2.39) and smokers (OR 1.54, 0.96-2.46).

Conclusions: The relative increase in cardiovascular risk associated with NSAID use was not modified by lifestyle or socioeconomic position.

Citing Articles

Influence of Low-Density Lipoprotein Cholesterol Levels on NSAID-Associated Cardiovascular Risks After Myocardial Infarction: A Population-Based Cohort Study.

Basem M, Bonnesen K, Pedersen L, Sorensen H, Schmidt M Clin Epidemiol. 2024; 16:281-291.

PMID: 38681781 PMC: 11049159. DOI: 10.2147/CLEP.S447451.


Cardiovascular safety of using non-steroidal anti-inflammatory drugs for gout: a Danish nationwide case-crossover study.

Bech-Drewes A, Bonnesen K, Hauge E, Schmidt M Rheumatol Int. 2024; 44(6):1061-1069.

PMID: 38581450 PMC: 11108875. DOI: 10.1007/s00296-024-05584-7.


Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.

Iyer P, Gao Y, Jalal D, Girotra S, Singh N, Vaughan-Sarrazin M Clin Rheumatol. 2023; 43(1):87-94.

PMID: 37498463 PMC: 10818008. DOI: 10.1007/s10067-023-06714-5.

References
1.
Bonnesen K, Ehrenstein V, Gronkjaer M, Pedersen L, Lash T, Schmidt M . Impact of lifestyle and socioeconomic position on use of non-steroidal anti-inflammatory drugs: A population-based cohort study. Pharmacoepidemiol Drug Saf. 2022; 32(4):455-467. DOI: 10.1002/pds.5571. View

2.
Montori V, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse J, Pacheco-Huergo V, Bryant D . Validity of composite end points in clinical trials. BMJ. 2005; 330(7491):594-6. PMC: 554039. DOI: 10.1136/bmj.330.7491.594. View

3.
Schmidt M, Sorensen H, Pedersen L . Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 2018; 362:k3426. PMC: 6122252. DOI: 10.1136/bmj.k3426. View

4.
Mejean C, Droomers M, van der Schouw Y, Sluijs I, Czernichow S, Grobbee D . The contribution of diet and lifestyle to socioeconomic inequalities in cardiovascular morbidity and mortality. Int J Cardiol. 2013; 168(6):5190-5. DOI: 10.1016/j.ijcard.2013.07.188. View

5.
Christensen A, Lau C, Kristensen P, Johnsen S, Wingstrand A, Friis K . The Danish National Health Survey: Study design, response rate and respondent characteristics in 2010, 2013 and 2017. Scand J Public Health. 2020; 50(2):180-188. DOI: 10.1177/1403494820966534. View